NCLT orders meetings on April 2 to approve NHIC demerger into Narayana Hrudayalaya

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹1856.80

prior close

₹1853.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.0%+0.9% vs market

Hospital peers, median of 23sector+0.0%-0.2% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Smallcap 250 and 0.2 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.2

15m

-0.6

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-1.0+0.9+0.0-0.2

Next day

-3.5-2.9-0.6-1.3-2.2

-7.1-5.0-2.1-4.2-2.9

-4.8-3.6-1.2-2.7-2.1

-4.8-3.9-0.9-2.1-2.7

-5.1-6.1+1.0-3.1-2.0

-6.4-4.5-1.9-1.7-4.7

15d

-12.5-11.3-1.2-9.3-3.2

-12.4-8.7-3.7-7.7-4.7

-3.1+4.2-7.3+3.3-6.4

+3.7+6.6-2.9+6.5-2.8

UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Narayana Hrudayalaya informed exchanges about NCLT Bengaluru ordered meetings on April 2, 2026, to approve a Scheme of Arrangement for demerger of NH Integrated Care Private Limited (NHIC) into Narayana Hrudayalaya. NCLT passed the order on Feb 13, 2026. Equity shareholders meet at 10 AM, secured creditors at 11:30 AM, unsecured creditors at 12:30 PM. Remote e-voting from March 30 to April 1. Cut-off date March 27, 2026.

Likely market impact

Shareholders will vote on April 2 to approve or reject the NHIC demerger scheme; a majority of three-fourths in value is needed for approval.